#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3348	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2290	266.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	375	C	224	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6258	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3548	308.8	0	.	n	.	0	T695C	SNP	695	695	T	1054	1054	C	367	C	217	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6258	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3548	308.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1997	1997	G	325	G	204	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6258	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3548	308.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2330	2330	C	287	CCACAC,CCAC	176,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6258	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3548	308.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2404	2404	A	301	A	192	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6258	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3548	308.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2956	2956	C	366	C	229	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	308	folP	855	855	100.0	folP.l15.c4.ctg.1	1614	33.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1036	1038	AGC	35;35;35	A;G;C	22;22;22	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	722	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3566	36.1	1	SNP	p	S91F	1	.	.	271	273	TTC	707	709	TTC	45;45;45	T;T;C	27;26;26	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	722	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3566	36.1	1	SNP	p	D95G	1	.	.	283	285	GGC	719	721	GGC	50;50;51	G;G;C	30;31;30	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	722	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3566	36.1	1	SNP	p	G95N	0	.	.	283	285	GGC	719	721	GGC	50;50;51	G;G;C	30;31;30	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	206	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1071	34.4	1	SNP	p	G45D	0	.	.	133	135	GGC	358	360	GGC	52;52;52	G;G;C	32;31;32	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	186	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1025	30.7	0	.	n	.	0	A197.	DEL	197	197	A	590	590	A	70	A	42	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2734	43.4	1	SNP	p	D86N	0	.	.	256	258	GAC	483	485	GAC	47;47;48	G;A;C	27;26;31	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2734	43.4	1	SNP	p	R87W	0	.	.	259	261	CGT	486	488	CGT	49;49;48	C;G;T	31;29;28	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2734	43.4	1	SNP	p	R87I	0	.	.	259	261	CGT	486	488	CGT	49;49;48	C;G;T	31;29;28	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2734	43.4	1	SNP	p	S87R	1	.	.	259	261	CGT	486	488	CGT	49;49;48	C;G;T	31;29;28	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	676	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2734	43.4	1	SNP	p	S88P	0	.	.	262	264	TCC	489	491	TCC	47;49;51	T;C;C	30;29;33	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	580	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2757	38.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1436	1438	GGC	35;35;35	G;G;C	22;22;23	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1186	1188	GCC	82;82;82	G;C;C	46;47;47	penA.42.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1189	1191	ATG	83;82;82	A;T;G	47;49;47	penA.42.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1201	1203	ACC	91;91;91	A;C;C	53;54;54	penA.42.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1201	1203	ACC	91;91;91	A;C;C	53;54;54	penA.42.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1702	1704	ACC	53;53;52	A;C;C	32;33;33	penA.42.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	A501P	1	.	.	1501	1503	CCG	1756	1758	CCG	51;51;57	C;C;G	31;29;33	penA.42.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	P501V	0	.	.	1501	1503	CCG	1756	1758	CCG	51;51;57	C;C;G	31;29;33	penA.42.001:1:1:P501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1879	1881	GGT	57;57;56	G;G,A;T	39;37,1;38	penA.42.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1888	1890	AGC	54;53;52	A;G;C,G	33;37;35,1	penA.42.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.42.001	penA.42.001	1	1	27	640	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2184	52.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1906	1908	CCG	41;41;40	C,G;C;G	24,1;24;21	penA.42.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1132	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2867	63.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1498	1500	CCG	32;32;32	C;C;G	19;21;19	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	324	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1827	31.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	505	505	C	23	C	12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	320	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	36.9	1	SNP	p	G120K	1	.	.	358	360	AAG	578	580	AAG	39;39;40	A;A;G	25;27;27	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	320	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	36.9	1	SNP	p	A121N	1	.	.	361	363	AAC	581	583	AAC	40;40;38	A;A;C	28;27;24	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	320	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1521	36.9	1	SNP	p	N121D	0	.	.	361	363	AAC	581	583	AAC	40;40;38	A;A;C	28;27;24	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1500	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4777	55.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	122	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	649	35.0	1	SNP	p	V57M	1	.	.	169	171	ATG	296	298	ATG	59;59;65	A;T;G	34;34;37	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
